Concepedia

Lin Ma

LM

Statistics

Publications

4

Citations

80

H-Index

4

Active since

2023

Affiliations

Hangzhou Medical College(Current)

Zhejiang University

Tongde Hospital of Zhejiang Province

Lin Ma is an author at Hangzhou Medical College specializing in molecular biology, molecular oncology, and targeted cancer therapy.

ORCID

Publications per year

2023–2023

4

Publications

4

Discovery of a Selective and Orally Bioavailable FGFR2 Degrader for Treating Gastric Cancer

Lin Ma, Yingying Li, Ruixiang Luo et al. · Journal of Medicinal Chemistry · 2023 · 32 citations

, , +9

POLR3G promotes EMT via PI3K/AKT signaling pathway in bladder cancer

Hualin Chen, Lin Ma, Wenjie Yang et al. · The FASEB Journal · 2023 · 22 citations

, , +17

Discovery of a potent and selective allosteric inhibitor targeting the SHP2 tunnel site for RTK-driven cancer treatment

Ruixiang Luo, Weitao Fu, Jingjing Shao et al. · European Journal of Medicinal Chemistry · 2023 · 16 citations · Full text

, , +14

Inhibition of SHP2 by the Small Molecule Drug SHP099 Prevents Lipopolysaccharide-Induced Acute Lung Injury in Mice

Shuhui Ye, Bowen Zuo, Lenan Xu et al. · Inflammation · 2023 · 10 citations

, , +6

1–4 of 4